https://www.selleckchem.com/pr....oducts/l-histidine-m
Despite the increasing prevalence and costs of breast cancer (BC), little is known about its adverse event (AE)-related costs in Asia. This study aimed to estimate the healthcare expenditures of AEs in patients with BC in Taiwan. This is a retrospective claims database analysis. The medical costs associated with BC AEs during the first-line treatment period were estimated by use of both a matching method and the generalized linear model (GLM). A total of 50,010 patients diagnosed with breast cancer were
Like
Comment
Share
